Simplex Trading
ALXN

Simplex Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Simplex Trading’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,600
Closed -$92K – 10024
2021
Q2 		$92K Buy
4,600
+4,512
+5,127% +$775K ﹤0.01% 6861
2021
Q1 		$1.34M Sell
88
-616
-88% -$95.3K ﹤0.01% 2079
2020
Q4 		$11M Buy
+704
New +$90.5K 0.01% 544
2020
Q3 		– Sell
-1,107
Closed -$12.4M – 8864
2020
Q2 		$12.4M Sell
1,107
-50
-4% -$5.31K 0.02% 436
2020
Q1 		$10.4M Buy
1,157
+712
+160% +$69.9K 0.02% 402
2019
Q4 		$4.81M Sell
445
-173
-28% -$18.5K 0.01% 825
2019
Q3 		$6.05M Buy
618
+102
+20% +$11.5K 0.02% 615
2019
Q2 		$6.76M Sell
516
-671
-57% -$86.5K 0.02% 543
2019
Q1 		$16M Buy
1,187
+714
+151% +$88.8K 0.04% 273
2018
Q4 		$4.61M Buy
473
+209
+79% +$24.7K 0.01% 619
2018
Q3 		$3.67M Sell
264
-522
-66% -$65.5K 0.01% 806
2018
Q2 		$9.76M Sell
786
-336
-30% -$39.3K 0.04% 352
2018
Q1 		$201K Buy
1,122
+389
+53% +$46.5K 0.01% 1231
2017
Q4 		$507K Sell
733
-224
-23% -$27.3K 0.02% 706
2017
Q3 		$1.26M Sell
957
-989
-51% -$134K 0.05% 305
2017
Q2 		$1.45M Buy
1,946
+1,582
+435% +$184K 0.06% 256
2017
Q1 		$65K Sell
364
-402
-52% -$51.8K ﹤0.01% 2133
2016
Q4 		$272K Buy
766
+332
+76% +$40.6K 0.02% 859
2016
Q3 		$166K Buy
434
+306
+239% +$39.4K 0.01% 1158
2016
Q2 		$37K Sell
128
-382
-75% -$54.2K ﹤0.01% 2350
2016
Q1 		$374K Buy
510
+190
+59% +$27.9K 0.03% 561
2015
Q4 		$256K Sell
320
-174
-35% -$30.4K 0.02% 723
2015
Q3 		$307K Buy
494
+172
+53% +$31.4K 0.02% 680
2015
Q2 		$636K Buy
322
+135
+72% +$23.3K 0.05% 332
2015
Q1 		$80K Buy
+187
New +$33.8K 0.01% 1243

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Simplex Trading's ALXN Position: Q3 2021 in Review

Simplex Trading sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 18,712 shares — an estimated $3.44M sold.

Simplex Trading first reported a position in ALXN in Q4 2014 and held it in 23 quarters. The position peaked at $12.8M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Simplex Trading reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Simplex Trading sold 18,712 Alexion Pharmaceuticals shares in Q3 2021, an estimated $3.44M.
  • Simplex Trading first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 23 quarters.
  • Simplex Trading's Alexion Pharmaceuticals position peaked at $12.8M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Simplex Trading's 13F filing for Q3 2021, filed 28 Oct 2021.